title: Should we treat herpes zoster with corticosteroid agents?
abstract: Herpes zoster is a common disease which is frequently followed by severe long-term pain--post-herpetic neuralgia. The arrival of new antiviral agents, not yet widely available, may lead to the neglect of the older, effective and inexpensive method of treatment with systemic corticosteroid agents. Evidence for the value of corticosteroid therapy is strong, while published data discouraging its use is weak. Consequently, the administration of these agents should be the standard treatment for painful acute zoster.
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002220:Carbamazepine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006562:Herpes Zoster / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D014221:Triamcinolone / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D014221:Triamcinolone; D002220:Carbamazepine; D011241:Prednisone